PureTech Health

Yahoo Finance • 11 months ago

PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion

Transaction Delivers KarXT, a First-in-Class M1 / M4 Muscarinic Receptor Agonist, with Differentiated Efficacy and Safety KarXT Is a Potential First-in-Class Treatment for Schizophrenia and as an Adjunctive Therapy, and First-in-Disease T... Full story

Yahoo Finance • 12 months ago

PureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophrenia

Results demonstrate KarXT was not associated with clinically meaningful increases in blood pressure in adults with schizophrenia KarXT demonstrated a mean change from baseline to week 8 in 24-hour ambulatory systolic blood pressure of -0.... Full story

Yahoo Finance • last year

Results of PureTech's Annual General Meeting

BOSTON, June 13, 2023--(BUSINESS WIRE)--The Annual General Meeting of PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech Health" or the "Company") was held at 11 a.m. EDT/4 p.m. BST on Tuesday, June 13, 2023. All of the resolutions... Full story

Yahoo Finance • 2 years ago

PureTech Health: Notice of Results

BOSTON, April 13, 2023--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") plans to publish its annual report and financial results on Friday, April 28, 2023, at 2:00 AM EDT/ 7:00 AM BST. The repor... Full story

Yahoo Finance • 2 years ago

PureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)

Project to leverage vocal biomarkers for cognitive assessment of patients ages 55 and above in home environment BOSTON, February 27, 2023--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a cli... Full story

Yahoo Finance • 2 years ago

PureTech’s LYT-300 (Oral Allopregnanolone) Demonstrates Oral Bioavailability, Tolerability and GABAA Receptor Target Engagement in Healthy Volunteers

Orally administered LYT-300 achieved blood levels of allopregnanolone at or above those associated with therapeutic effect.1 Allopregnanolone is a natural neurosteroid with proven efficacy that is currently only available as a 60-hour intr... Full story

Yahoo Finance • 2 years ago

10 Best Immunology Stocks to Invest In

In this article, we discuss the 10 best immunology stocks to invest in. If you want to read about some more immunology stocks, go directly to 5 Best Immunology Stocks to Invest In. Immunology is the study of the immune system of higher or... Full story

Yahoo Finance • 2 years ago

PureTech to Present at the Morgan Stanley Global Healthcare Conference

BOSTON, September 08, 2022--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today... Full story

Yahoo Finance • 2 years ago

PureTech Founded Entity Akili Announces Phase 3 Study of Digital Treatment in Children with ADHD Begun by Shionogi in Japan

Pivotal study follows successful Phase 2 trial, which demonstrated improvements in attention function as compared to both treatment as usual and single task video game groups Pivotal Data Readout expected in 2H2023 BOSTON, August 01, 202... Full story

Yahoo Finance • 2 years ago

FDA panel to review Moderna vaccine in children aged 6 to 17, and Rolling Stones front man Mick Jagger tests positive for COVID

An independent panel of advisers to the Food and Drug Administration will meet later Tuesday to discuss the use of the Moderna vaccine in children aged 6 to 17.... Full story

Yahoo Finance • 3 years ago

PureTech to Present at the UBS Global Healthcare Conference

BOSTON, May 17, 2022--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated med... Full story

Yahoo Finance • 3 years ago

PureTech Announces Share Buyback Program Update

BOSTON, May 09, 2022--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated med... Full story